Pharmafile Logo
Pharmafocus logo
Advanced Search

Mental health research network launched

June 10, 2004

News

Abbott buys heart drug from Aventis for $300 million

June 10, 2004

Chicago-based Abbott Laboratories has bought the marketing and manufacturing rights for cardiovascular drug trandolapril from Aventis, in a deal worth …

News

New schizophrenia drug Abilify gets European go-ahead

June 10, 2004

Abilify, Bristol-Myers Squibb and Otsuka's antipsychotic has received European Union marketing approval and will be promoted for having fewer side …

News

Novo Nordisk claims new product superior to Lantus

June 10, 2004

News

Lipitor halves stroke risk in diabetes patients

June 8, 2004

New Lipitor data suggests the drug cut the risk of stroke by half in diabetes patients, the compelling evidence potentially …

News

Shire relocates R&D headquarters to US

June 3, 2004

Shire Pharmaceuticals has relocated its research and development headquarters to the US as the company looks to increase its penetration …

News

Oxford BioMedica one step closer to Holy Grail of nerve damage

June 3, 2004

The promise of a gene-based technology which might one day cure spinal injuries and paralysis has moved one step closer …

News

GlaxoSmithKline ‘misled doctors’ over antidepressant safety

June 3, 2004

News

PCT claims bullying over private contract

June 3, 2004

An NHS trust chairman has accused the government of bullying it into awarding a contract to a private firm, resulting …

News

Lilly launches first non-stimulant ADHD treatment

June 3, 2004

News

Unmet needs in arthritis

June 3, 2004

Although there is no cure for rheumatoid arthritis (RA), a wide range of drugs are involved in its treatment. Similar …

Feature

CROs: flexible or overstretched?

June 3, 2004

If only I had known then what I know now about the labyrinthine world of Contract Research Organisations (CROs). This …

Feature

Lost in translation?

June 2, 2004

Feature

Counterfeit medicines on the rise

June 1, 2004

The World Health Organisation (WHO) estimates that up to 10% of medicines worldwide may be counterfeit, costing the pharmaceutical industry …

Feature

MPs call for NHS obesity reduction targets

May 27, 2004

News

Making the most of your talent

May 27, 2004

The vast majority of pharma executives would argue that having a large number of products in any company's portfolio should …

Feature

Roche prescribing data to support NICE uptake

May 27, 2004

Roche is to provide NICE with regular updates on patient access to its treatments to help increase the uptake of …

News

Arrhythmias added to ‘ahead of schedule’ heart disease NSF

May 27, 2004

News

NICE strikes deal with industry on data confidentiality

May 26, 2004

The industry and NICE have reached agreement on how the cost and clinical effectiveness body can meet demands for transparency …

News

The science of compliance

May 26, 2004

Feature
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026